Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trial.
The mechanisms by which selective serotonin re-uptake inhibitors (SSRI) act in depressed patients remain unknown. The serotonergic neurotransmitter system and the hypothalamic-pituitary-adrenal (HPA) system may interact. The aim of the AGENDA trial was to investigate whether long-term intervention w...
Main Authors: | Ulla Knorr, Maj Vinberg, Allan Hansen, Marianne Klose, Ulla Feldt-Rasmussen, Linda Hilsted, Jørgen Hasselstrøm, Ulrik Gether, Per Winkel, Christian Gluud, Jørn Wetterslev, Lars Vedel Kessing |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3124484?pdf=render |
Similar Items
-
Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.
by: Ulla Knorr, et al.
Published: (2012-01-01) -
Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression
by: Paulson Olaf, et al.
Published: (2009-08-01) -
Hypopituitarism in Traumatic Brain Injury—A Critical Note
by: Marianne Klose, et al.
Published: (2015-07-01) -
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS
by: Dorte Glintborg, et al.
Published: (2018-03-01) -
Less known aspects of central hypothyroidism: Part 1 – Acquired etiologies
by: Salvatore Benvenga, et al.
Published: (2018-12-01)